Cited by 164Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsTreatment of Major Depression

The DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.

Depression in Alzheimer’s Disease: Epidemiology, Mechanisms, and Treatment

Huang, Yu-Yuan, Gan, Yi-Han, Yang, Liu, Cheng, Wei, Yu, Jin-Tai·2024·Biological Psychiatry

DOI 10.1016/j.biopsych.2023.10.008

Open this paper in CoChat — free account

Abstract

Depression and Alzheimer's disease (AD) are substantial public health concerns. In the past decades, a link between the 2 disease entities has received extensive acknowledgment, yet the complex nature of this relationship demands further clarification. Some evidence indicates that midlife depression may be an AD risk factor, while a chronic course of depression in late life may be a precursor to or symptom of dementia. Recently, multiple pathophysiological mechanisms have been proposed to underlie the bidirectional relationship between depression and AD, including genetic predisposition, immune dysregulation, accumulation of AD-related biomarkers (e.g., amyloid-β and tau), and alterations in brain structure. Accordingly, numerous therapeutic approaches, such as pharmacology treatments, psychotherapy, and lifestyle interventions, have been suggested as potential means of interfering with these pathways. However, the current literature on this topic remains fragmented and lacks a comprehensive review characterizing the association between depression and AD. In this review, we aim to address these gaps by providing an overview of the co-occurrence and temporal relationship between depression and AD, as well as exploring their underlying mechanisms. We also examine the current therapeutic regimens for depression and their implications for AD management and outline key challenges facing the field.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2023.10.008

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728
Social stress induces neurovascular pathology promoting depression
Menard, C., Pfau, M. L., Hodes, G. E., Kana, V., Wang, V. X., Bouchard, S., Takahashi, A., Flanigan, M. E., Aleyasin, H., LeClair, K. B., et al. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0010-3 · Cited by 1,028
Resting-state functional connectivity in major depressive disorder: A review
Mulders, P. C., van Eijndhoven, P. F., Schene, A. H., Beckmann, C. F., & Tendolkar, I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.014 · Cited by 884
Patient Preference for Psychological vs Pharmacologic Treatment of Psychiatric Disorders: A Meta-Analytic Review
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800
The role of adult hippocampal neurogenesis in brain health and disease
Toda, T., Parylak, S. L., Linker, S. B., & Gage, F. H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0036-2 · Cited by 719
Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
Enache, D., Pariante, C. M., & Mondelli, V. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.015 · Cited by 615
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60830-1 · Cited by 532
Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study
Singh-Manoux, A., Dugravot, A., Fournier, A., Abell, J., Ebmeier, K., Kivimäki, M., & Sabia, S. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0660 · Cited by 529
Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier
Storck, S. E., Meister, S., Nahrath, J., Meißner, J. N., Schubert, N., Di Spiezio, A., Baches, S., Vandenbroucke, R. E., Bouter, Y., Prikulis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81108 · Cited by 477

Show all 133 references

Sorted by citations

A 2025 update on treatment strategies for the Alzheimer’s disease spectrum
Wu, C.-K., & Fuh, J.-L. (2025) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001252 · Cited by 77
“43”
Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies
Wang, S., Liao, Z., Zhang, Q., Han, X., Liu, C., & Wang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1484373 · Cited by 67
Population attributable fractions for risk factors for dementia in seven Latin American countries: an analysis using cross-sectional survey data
Paradela, R. S., Calandri, I. L., Castro, N. P., Garat, E., Delgado, C., Crivelli, L., Yaffe, K. S., Ferri, C. P., Mukadam, N., Livingston, G., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00275-4 · Cited by 50
The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer's disease: Research progress and insights
Mao, Y., Zhang, L., Zhang, C., Qin, L., Liao, X., & Zhao, L. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127692 · Cited by 43
The microbiota–gut–brain axis in mental and neurodegenerative disorders: opportunities for prevention and intervention
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 48
Herbal remedies for Alzheimer’s disease: neuroprotective mechanisms and cognitive enhancement potential
Kirubakaran, D. (2025) · Digital Chinese Medicine · doi:10.1016/j.dcmed.2025.05.002 · Cited by 39
The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease
Antonioni, A., Martorana, A., Santarnecchi, E., Hampel, H. J., & Koch, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70337 · Cited by 31
Engineered nanoparticles for the treatment of Alzheimer’s disease
Jia, J., Zhao, S., Zhao, J., & Gao, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1510798 · Cited by 24
Pyroptosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential
Tang, T. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01579-5 · Cited by 17
Understanding late-life depression: focus on inflammation
Teixeira, A. L., de Miranda, A. S., Venna, V. R., Himali, J. J., & Bauer, M. E. (2025) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001022 · Cited by 18
Associations between cardiometabolic multimorbidity and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
Li, Q., Hu, H., Zhang, G.-W., Hu, H., Ou, Y., Huang, L., Wang, A.-Y., Gao, P., Ma, L., Tan, L., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01396-w · Cited by 15
Self-citation
MicroRNA-specific targets for neuronal plasticity, neurotransmitters, neurotrophic factors, and gut microbes in the pathogenesis and therapeutics of depression
Chen, C.-Y., Wang, Y., Lei, L., & Zhang, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111186 · Cited by 14
Changes in dementia risk along with onset age of depression: a longitudinal cohort study of elderly depressed patients
Jang, Y. J., Kim, M.-J., Moon, Y. K., Lim, S., & Kim, D. K. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06683-w · Cited by 13
The mediating effect of activities of daily living (ADL) disability on the association between depressive symptoms and cognitive impairment in older adults: a National study
Yao, X., Han, D., & Lu, Q. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06380-z · Cited by 13
Segregated supramammillary-dentate gyrus circuits modulate cognitive and affective function in healthy and Alzheimer’s disease model mice
Luo, Y., Li, L., Chen, Z.-K., Dong, P., Xie, L., Farmer, W. T., Yu, Q.-S., Jiang, L.-X., Su, W.-K., Liu, H., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.006 · Cited by 14
Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation
Hermann, D. M., Bacigaluppi, M., Bassetti, C. L., Bassotti, G., Boltze, J., Chan, A., Dalkara, T., Denes, A., Diez-Tejedor, E., Dodel, R., et al. (2025) · Exploration of Neuroscience · doi:10.37349/en.2025.1006106 · Cited by 13
Immunopsychiatry of late life depression: role of ageing-related immune/inflammatory processes in the development and progression of depression
Teixeira, A. L., Barbosa, I. G., Bauer, M. E., & de Miranda, A. S. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.10019 · Cited by 12
Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies
Twait, E. L., Kamarioti, M., Verberk, I. M. W., Teunissen, C. E., Nooyens, A. C. J., Verschuren, W. M. M., Visser, P. J., Huisman, M. A., Kok, A. A. L., Slagboom, P. E., et al. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.03.004 · Cited by 16
Research progress on the mechanism of antidepressant effect of salidroside
Ao, W., Gao, W., & Li, T. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115205 · Cited by 10
Smart responsive biomaterials for spatiotemporal modulation of functional tissue repair
He, X., Han, Z., Ruan, Y., Wang, Z., Liao, B., Li, X., Tan, J., Han, X., Shen, J., & Bai, D. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102063 · Cited by 14
Effect of depression on risks of Alzheimer’s disease and vascular dementia: A real-world longitudinal study
Xu, H., Wang, Y., Shao, W., Yang, J., Wei, X., Tong, X., Hu, C., Gong, E., Feng, L., Zhou, M., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116716 · Cited by 10
Neurobiological and therapeutic landmarks of depression associated with Alzheimer’s disease dementia
Untu, I., Davidson, M., Stanciu, G. D., Rabinowitz, J., Dobrin, R., Vieru, D. S., & Tamba, B.-I. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1584607 · Cited by 12
Pathophysiology of cognitive impairment in chronic kidney disease
Merlino, L., Tollitt, J., Dunne, R. A., & Kalra, P. A. (2025) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001117 · Cited by 9
Disease trajectories before dementia: evidence from a large-scale community-based prospective study
Li, J., Xia, D., Cui, M., Wang, Y., Li, J., Li, J., Chen, X., Suo, C., & Jiang, Y. (2024) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.122 · Cited by 9
Machine learning to detect Alzheimer's disease with data on drugs and diagnoses
Wallensten, J., Wachtler, C., Bogdanović, N., Olofsson, A., Kivipelto, M., Jönsson, L., Petrović, P., & Carlsson, A. C. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100115 · Cited by 9
The Association Between Caregiver Psychosocial Factors and Depressive Symptoms in People With Dementia: A Systematic Review and Meta‐Analysis
Ning, W., Wang, S., Xu, Y., & Cheung, D. S. K. (2025) · Journal of Advanced Nursing · doi:10.1111/jan.17093 · Cited by 9
P-tau217 as a Biomarker in Alzheimer’s Disease: Applications in Latin American Populations
Varela-Vidales, C. A., Martínez-Hernández, A., Hernández-Castellanos, E., & Delgado-Lara, D. L. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146633 · Cited by 9
Environmental and genetic risk factors of depression converge on neuronal dysfunction driven by changes in cholesterol homeostasis
Oberst, P., Xu, N., Munguba, H., Zhang, C., Zhong, A., Zhou, T., Liston, C. M., Levitz, J., & Studer, L. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.08.011 · Cited by 8
A perspective on Alzheimer’s disease: exploring the potential of terminal/paradoxical lucidity and psychedelics
Lin, C., Du, X., & Wang, X. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00761-5 · Cited by 8
RETRACTED: Molecular mechanisms of MAPK9, BAX, and TFEB proteins: Genetic correlations between oxidative stress and autophagy pathways in Alzheimer's disease
Huang, X., Wang, J., Zhao, X., Sooranna, S. R., Liao, B., Jian, C., Shang, J., & Li, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143196 · Cited by 7
Retracted
A Narrative Review Evaluating Diet and Exercise as Complementary Medicine for the Management of Alzheimer’s Disease
Szabo‐Reed, A. N., & Key, M. N. (2025) · Nutrients · doi:10.3390/nu17111804 · Cited by 8
Specific midlife depressive symptoms and long-term dementia risk: a 23-year UK prospective cohort study
Frank, P., Singh‐Manoux, A., Pentti, J., Batty, G. D., Sommerlad, A., Steptoe, A., Livingston, G., Howard, R. J., & Mika Kivimaki, B. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00331-1 · Cited by 7
Expose to volatile organic compounds is associated with increased risk of depression: A cross-sectional study
Ma, T., Wang, X., He, W., Zhang, G., Shan, T., Song, X., Yang, X., Ma, J., Chen, L., Niu, P., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.028 · Cited by 7
Deciphering the Functions of Raphe–Hippocampal Serotonergic and Glutamatergic Circuits and Their Deficits in Alzheimer’s Disease
Yu, W., Zhang, R., Zhang, A., & Mei, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031234 · Cited by 7
Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression
Moyano, B. P., Zullo, L., Rouaud, O., Vandel, P., von Gunten, A., & Allali, G. (2024) · Neurodegenerative Diseases · doi:10.1159/000541783 · Cited by 6
The impact of sleep and exercise on brain atrophy in mild cognitive impairment
Mian, M., Tahiri, J., Habbal, S., Aftan, F., & Reddy, P. H. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.112023 · Cited by 8
Blood lipid profiles and mood disorders: A principal component analysis of UK Biobank data reveals distinct associations with depression and bipolar disorder
Liu, X., Li, Y., Yang, W., Chen, X., Li, F., Chen, N., Yin, H., & Cui, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.02.040 · Cited by 7
The Transition to Caregiver in Advanced Alzheimer’s Disease: From Emotional Connection to Care Responsibility—A Grounded Theory Approach
Dellafiore, F., Diamanti, O., Guardamagna, L., Modena, G. M., Servi, P., Rotondo, D. A., Nania, T., Saba, A., & Artioli, G. (2025) · Nursing Reports · doi:10.3390/nursrep15080284 · Cited by 6
Isoacteoside alleviates LPS-induced depressive-like behaviors in mice by inhibiting neuroinflammation through regulating microglial polarization and oxidative stress
Bi, J., Zhang, H., Jia, W., Huang, X., Dong, Y., Dong, Y., Xie, Y., Li, R., Chen, S., Zhao, Z., et al. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00298-7 · Cited by 6
Nanoplastics trigger glial–neuronal collagen signaling miscommunication to exacerbate cognitive impairment in Alzheimer's disease
Zhong, Y., Fan, B., Yang, X., Huang, Y., Liang, B., Zhiming, 任晓虎, Xian, H., Deng, Y., Feng, Y., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71096 · Cited by 7
Self-citation
From APOE to cellular changes: Unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease
Jiang, F., Wang, N., & Meng, Q. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360321 · Cited by 6
The Neurosteroid Hormone Vitamin D: Modern Prospects
Lebedev, A. S., Shevlyakov, A. D., Ilyin, N. P., Galstyan, D. S., Golushko, N. I., & Kalueff, A. V. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024060024 · Cited by 5
Traumatic brain injury and Alzheimer’s disease related neurodegenerative diseases: Insights from animal models
Zhao, X., & He, Z. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104979 · Cited by 5
Psychiatric symptoms and alzheimer's disease: Depression-anxiety comorbidity effects and their neurobiological mediating mechanisms
Yang, J., Xue, W., Zheng, W., Zhang, H., & Tang, C. T. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120594 · Cited by 6
Nutrition and Neuroinflammation: Are Middle-Aged Women in the Red Zone?
Bernier, V., Chatelan, A., Point, C., & Strauss, M. (2025) · Nutrients · doi:10.3390/nu17101607 · Cited by 6
Cystatin F-a key player in central nervous system disease
Wang, Y.-T., Li, Q., Liu, J., Chen, C., Ding, H.-X., Zha, X., & Zhang, K. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03526-z · Cited by 5
Carnosine Mitigates Cognitive Impairment and Dopamine Release in an Okadaic Acid-Induced Zebrafish Model with Alzheimer’s Disease-like Symptoms
Chern, H., Caruso, G., Desaire, H., & Jarošová, R. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00596 · Cited by 6
Mining key circadian biomarkers for major depressive disorder by integrating bioinformatics and machine learning
Shi, Y., Zhu, J., Hou, C., Li, X., & Tong, Q. (2024) · Aging · doi:10.18632/aging.205930 · Cited by 4
Predicting depression risk in COPD patients: a model based on NHANES 2007–2012 data
Zhang, J., & Zhou, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-23342-7 · Cited by 5
Migraine is a risk factor for dementia: a systematic review and meta-analysis of cohort studies
Zhu, W., Zhan, Y., Pei, J., Fu, Q., Wang, R., Yang, Q., Guan, Q., & Zhu, L. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02078-0 · Cited by 4
Narcissoside from Bupleurum chinense DC. Alleviates depression by enhancing adult hippocampal neurogenesis via the TREM2/PI3K/Akt pathway
Shuang, R., Tong, Y. A., Wang, X., Hou, D., Yang, H., Xu, S., & Chen, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120323 · Cited by 4
5-Lipoxygenase triggers depressive-like behaviors via activating NLRP3-induced pyroptosis in CUMS-exposed mice
Zhang, Y., Zheng, Y., Xu, T., Wang, Q., Sang, T., Sheng, X., Fang, Y., & Chu, L. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110704 · Cited by 4
Treatment with a botanical mixture of cannabidiol:Δ9-tetrahydrocannabinol enhances microglial phagocytosis and shapes amyloid plaques in a mouse model of Alzheimer’s disease
Esteban, S. R. D. M., Grande, M. T., Martínez-Relimpio, A. M., Herráez‐Aguilar, D., Mostany, R., Hillard, C. J., Hind, W. H., & Romero, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118902 · Cited by 4
The association of Alzheimer's disease and related dementias blood‐based biomarkers with depressive symptoms
Bacci, J. R., Ryan, J. L., Murray, A. M., Wu, Z., Woods, R. L., Berk, M., & Mielke, M. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.71007 · Cited by 4
Differential Transcriptional Programs Reveal Modular Network Rearrangements Associated with Late-Onset Alzheimer’s Disease
Pérez-González, A. P., de Anda‐Jáuregui, G., & Lemus, E. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052361 · Cited by 5
Identification of HIBCH and MGME1 as Mitochondrial Dynamics‐Related Biomarkers in Alzheimer's Disease Via Integrated Bioinformatics Analysis
Liu, X., Feng, F., Xie, S., Ma, Y., Wang, Y., Zhang, F., Wu, H., & Huang, S. (2025) · IET Systems Biology · doi:10.1049/syb2.70018 · Cited by 4
Visualization of Microcirculation at Acupoints in vivo of Alzheimer’s Disease Animal Model with Photoacoustic Microscope: A Pilot Study
Jiang, J. H., Wang, Z., Yu, R., Yang, J., Wang, Q., Guo-qing, W., Tao, Y., Zhao, X., Wang, Y., Li, Z., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230193 · Cited by 3
Sound and Alzheimer’s Disease—From Harmful Noise to Beneficial Soundscape Augmentation and Music Therapy
Belojević, G. (2024) · Noise and Health · doi:10.4103/nah.nah_162_24 · Cited by 4
The Role of Sirt1 in Regulating Inflammatory Cytokines and Oxidative Stress in the Transition Mechanism from Depressive Disorder to Alzheimer’s Disease
Zou, J., Liu, L., Chai, F., Shan, Q., & Wang, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05084-0 · Cited by 3
The impact of chronic stress on cortical thickness in patients with depression
Li, N., Li, Y., Lu, Y., Zhang, K., Wang, S., & Wang, C. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1554476 · Cited by 3
Polygonatum sibiricum polysaccharide ameliorates neurotoxicity in Alzheimer disease mice by inhibiting endoplasmic reticulum stress and lipid raft formation through AMPK/GSK3β/Nrf2 pathway
Wu, S., Liu, W., & Changying, Z. (2025) · Neurological Research · doi:10.1080/01616412.2025.2559431 · Cited by 3
Association between brain volume and depression in Alzheimer's disease: Neuroimaging insights
Tang, C., Yang, J., Lei, X., Zhang, M., Chen, Y., Peng, X., & He, D. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71120 · Cited by 4
Global, regional, and national burden of depressive disorders in older adults from 1990 to 2021, with projections of prevalence to 2050: a trend analysis for the Global Burden of Disease Study 2021
Chen, M., Li, M., Wan, D., & Zha, J. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121531 · Cited by 3
The Impact of the CALLY Index on All‐Cause Mortality in Patients With Depression: A Longitudinal Analysis Using NHANES Data
Zhang, Y. J., Sa, R., Jia, H., Wang, X., Ma, R., & Tong, L. (2026) · Health Science Reports · doi:10.1002/hsr2.72387 · Cited by 4
Beyond Wolfram Syndrome 1: The WFS1 Gene’s Role in Alzheimer’s Disease and Sleep Disorders
Caruso, V., & Rigoli, L. C. (2024) · Biomolecules · doi:10.3390/biom14111389 · Cited by 3
Cognitive therapies and their impact on neuropsychiatric symptoms in mild cognitive impairment or dementia: a scoping review
Consuegra, B. L., Carnes, A., Torres-Hidalgo, P., & Piñol‐Ripoll, G. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1547619 · Cited by 3
Palmitoylation-related gene ZDHHC22 as a potential diagnostic and immunomodulatory target in Alzheimer’s disease: insights from machine learning analyses and WGCNA
Mao, S., Zhao, X., Wang, L., Man, Y., & Li, K. (2025) · European journal of medical research · doi:10.1186/s40001-025-02277-0 · Cited by 3
Phenotype Scoring of Population Scale Single-Cell Data Dissects Alzheimer's Disease ComplexityPreprint
He, C.-F., Li, A. Z., Arachchilage, K. H., Gupta, C., Huang, X., Zhao, X., Girdhar, K., Voloudakis, G., Hoffman, G. E., Bendl, J., et al. (2024) · medRxiv · doi:10.1101/2024.11.01.24316586 · Cited by 3
Screen, Sample, Stratify: Biomarkers and Machine Learning Compress Dementia Pathways
Battaglia, S., & Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14010159 · Cited by 2
The Biflavonoid Agathisflavone Regulates Microglial and Astrocytic Inflammatory Profiles via Glucocorticoid Receptor
Almeida, Á. M. A. N., dos Santos, C. C., Takahashi, D., da Silva, L. P., de Sousa, V. M., de Santana, M. R., Arco, A. E. D., dos Santos, B. L., David, J. M., da Silva, V. D. A., et al. (2025) · Molecules · doi:10.3390/molecules30051014 · Cited by 2
Electroconvulsive therapy for neuropsychiatric symptoms in a patient with posterior cortical atrophy associated with Alzheimer's disease and a history of depression: A case report and review of the literature
Moyano, B. P., Swierkosz-Lenart, K., Schuster, J., Garcia, N. R. P., Rouaud, O., Vandel, P., & von Gunten, A. (2025) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2025.100256 · Cited by 2
Cholinergic G protein‐coupled bile acid receptor 1 (TGR5/GPBA) in the medial septal orchestrates adult hippocampal neurogenesis and cognition in Alzheimer's disease mice
Nie, R., Zhang, Q., Tan, X., Hu, S., Zhou, X., Jiang, W., Guo, B., Cao, X., Yuan, D., Long, Y., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70185 · Cited by 3
Electroacupuncture Prevents Against AD‐Like Phenotypes in APP/PS1 Mice: Investigation of the Mechanisms From Cerebral Microangiopathy
Yang, C., Li, B., Yang, S. ‐., Wang, X., Zhu, G., & Wang, J. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70696 · Cited by 2
Gray matter structural and molecular signatures in Alzheimer's disease and late-life depression
Yang, S., Wang, X., Yan, Y., Zhang, J., Wei, Y., Zhang, D., & Yao, W. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120915 · Cited by 2
Assessing the comorbidity between asthma and depression through polygenic risk scoring and time-to-event models
Wang, X., He, J., Cabrera‐Mendoza, B., Qiu, D., Mao, Z., Gu, W., Liu, Y., Kim, J. H., & Polimanti, R. (2026) · BMC Medicine · doi:10.1186/s12916-026-04646-w · Cited by 2
Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models
Fonseca, C., Gouveia, F., Silva, S., Castanheira, S., Driouech, L., Matos, A. M., Barbosa, R. M., Camins, A., Falcão, A. C., Ettcheto, M., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119298 · Cited by 2
The mechanisms and strategies for Alzheimer’s disease prevention: An update
Han, M., Wang, N., Song, M., Liu, C., Wu, Y., Yin, J., Jin, L., Jin, W., & Gao, Z. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.04.007 · Cited by 3
Organelle interactome disruption: The systemic pathological mechanisms and therapeutic prospects of mitochondria-lysosome-ER crosstalk in Alzheimer's disease
Xing, L., Liu, A., Gao, W., Li, J., Yao, M., Song, J., Duan, P., & Li, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103145 · Cited by 2
A novel bifunctional peptide predicted to target neuropeptide Y4 and GLP-1 receptors alleviates cognitive deficits in 5 × FAD mice by modulating cGAS-STING-mediated neuroinflammation
Feng, Y., 张彩利, Wei, Y., Liu, E., Sun, H., Flatt, P., Gault, V. A., Irwin, N., Hölscher, C., Hao, L., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118074 · Cited by 2
Nutritional care for patients with neurodegenerative diseases in the outpatient practice of a neurologist
Владимировна, Г. Е., Сорокина, Т. А., & Zorkova, А. V. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512501176 · Cited by 2
From genes to drugs: targeting Alzheimer’s with circadian insights
Li, Z., Li, X., Su, L., Zhang, Z., Guo, H., Ge, Y., Dong, F., & Zhang, F. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1527636 · Cited by 2
Hearing Loss and Alzheimer Disease
Stadio, A. D., Hamiter, M. J., Roccamatisi, D., & Lalwani, A. K. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_526 · Cited by 2
The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
Wu, J., Sun, H., Zhao, Y., Lian, L., Bian, H., Guo, Y., Li, D., & Huang, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1538837 · Cited by 1
Comorbidity of Depression and Dementia: Epidemiological, Biological, and Therapeutic Aspects
Петрова, Н. Н. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01822-y · Cited by 1
Antidepressant use in dementia: Assessing effective strategies for a vulnerable population
Cozza, M., Fimognari, F. L., Castagna, A., & Boccardi, V. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106340 · Cited by 1
Possible and Probable Dementia and Depressive/Anxiety Symptoms in U.S. Older Adults: One-Year Follow-Up
Choi, N. G., Zhou, Y., & Marti, C. N. (2025) · Journal of Aging and Health · doi:10.1177/08982643251369347 · Cited by 1
Effectiveness of family support-based companion video sharing to improve depression in perinatal maternity: a randomized controlled trial study protocol
Bao, R., Yang, C., Zhu, R., Li, W., Bai, Y., Jiang, Y., & Zhang, G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1641154 · Cited by 1
Critical nodes in precision diagnosis and treatment of Alzheimer's disease: exploration of multidimensional biomarkers and prospects for targeted intervention
Zuo, Y., Ding, X., Sun, Y., Wang, L., Song, Y., Zhao, Z., & Liu, C. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123734 · Cited by 1
Combined Influence of Depressive Symptoms and Estimated Glomerular Filtration Rate on Cognition Decline in US Adults
Yang, Y., Hu, H., Lv, T., Li, J., Yang, Y. J., Chen, S., He, Y., & Fei, Q. (2025) · Brain and Behavior · doi:10.1002/brb3.70997 · Cited by 1
The role of elevated depressive symptoms in the incident mild cognitive impairment in China: a 9-year prospective cohort study of middle-aged and older Chinese adults (2011–2020)
Gao, S., Xiao, L., Lv, J., & Fan, J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1726680 · Cited by 1
The role of the MIND diet in Alzheimer's disease patients: A case-control study on malnutrition and depression
Öztürk, N. K., & Türel, C. A. (2025) · Nutrition · doi:10.1016/j.nut.2025.113077 · Cited by 1
Depressive symptoms mediate the relationship between cognitive reserve and cognitive performance in middle-aged and older Chinese adults: evidence from population-based and clinical PET cohorts including cognitively normal and cognitively impaired participants
Gu, Y., Li, X., Chen, N., & Wang, F. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1708268 · Cited by 1
Social Determinants of Health, Genetic Susceptibility, and Risk of Dementia: A Prospective Cohort Study
Chen, H., Wang, X.-L., Gao, J., Li, C., Huang, Q., Zhong, W.-F., Xie, J.-H., Liu, W., Liu, D., Li, Z., et al. (2026) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2026.108294 · Cited by 1
Polygala Tenuifolia Willd. Ameliorates Neuronal Damage in Alzheimer’s Disease Model Mice by Regulating Ferroptosis Through Modulation of the Nrf2/SLC7A11/GPX4 Axis
Qian, G., Zou, J., Huang, Q., Gao, M., Sun, Y., Wu, X., Gu, L., Qian, Y., & Wu, X. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05657-2 · Cited by 1
The novel therapeutic strategy of myricetin/chitooligosaccharide/astaxanthin, as potent multi-target-directed ligands for the potential treatment of Alzheimer's disease with comorbid depression
He, S., Lin, Z., Zhou, X., Wang, Q., 方超华, JIN, Q., & Guan, L. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178806 · Cited by 1
Triglyceride–glucose index, genetic predisposition, and incident depression: a prospective cohort study from the UK Biobank
Hu, W., Liu, T.-S., Shen, Z., Tian, G., Jia, C.-X., & Liu, B.-P. (2026) · Psychological Medicine · doi:10.1017/s0033291726103535 · Cited by 1
Risk and protective factors associated with depressive symptoms in older adults with visual impairment: a systematic review
Suzuki, H., Leutwyler, H. C., Torres, J. M., Covinsky, K. E., & Wallhagen, M. I. (2026) · The Gerontologist · doi:10.1093/geront/gnag133 · Cited by 1
Associations of Midlife Vascular Risk Factors With Late‐Life Depressive Symptoms: Findings From the ARIC Study
Kanetkar, S., Morrill, V. N., Egle, M. S., Walker, K. A., Schneider, A. L. C., Peters, M. E., Mosley, T. H., Shrestha, S., & Gottesman, R. F. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.049924 · Cited by 1
AI-based characterization of Alzheimer’s disease phenotypes from population-scale single-cell data
He, C., Li, A. Z., Arachchilage, K. H., Gupta, C., Xiang, H., Zhao, X., Sirois, C. L., Hong, A., Zeng, B., Dillard, C., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04128-1 · Cited by 4
NEUROPROTEÇÃO ATRAVÉS DO ESTILO DE VIDA, ABORDAGENS NÃO FARMACOLÓGICAS NA DOENÇA DE ALZHEIMER: UMA REVISÃO INTEGRATIVA
Mouro, G. H. S., Filho, L. L. D. S., de Queiroz, L. F. E., Melo, J. P. F., Yano, J. F. R., Cardoso, E. L., Vieira, C. Q., GUIMARÃES, A. B. F., Elias, H. M., & Arruda, J. T. (2025) · Cognitus Interdisciplinary Journal · doi:10.71248/pjt6mm07 · Cited by 1

Authors: Huang, Y.-Y., Gan, Y.-H., Yang, L., Cheng, W., & Yu, J.-T.
Affiliations: Shanghai Medical College of Fudan University (CN)
Corresponding author: Yu, Jin-Tai
ORCID: Cheng, Wei
Yu, Jin-Tai
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2024-06
Volume: 95
Issue: 11
Pages: 992-1005
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2023.10.008
OpenAlex: W4387802230
Cited by: 164
References: 133
Citations by year: 2026: 63 · 2025: 83 · 2024: 18
FWCI: 7.49
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: depression, Alzheimer's disease, dementia, geriatric depression, bidirectional relationship, amyloid-beta, tau protein, immune dysregulation, genetic susceptibility, brain structure, pharmacotherapy, psychotherapy, lifestyle intervention, risk factors
MeSH terms: Alzheimer Disease, Antidepressive Agents, Depression, Depressive Disorder, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Depression in Alzheimer’s Disease: Epidemiology, Mechanisms, and Treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks